106243-16-7Relevant academic research and scientific papers
Two Novel Syntheses of the Histamine H3 Antagonist Thioperamide
Lange, Jos H. M.,Wals, Henri C.,Hoogenband, Adri van den,Kuilen, Aalt van de,Hartog, Jack A. J. den
, p. 13447 - 13454 (2007/10/02)
The previously described route for the synthesis of the histamine H3 antagonist thioperamide 3 has been improved considerably.Furthermore, two straightforward novel synthetic routes towards 3 are described herein.The last synthetic route (Scheme 3) is preferable as it is very suitable for the production of multigram quantities of thioperamide 3.
Design of potent non-thiourea H3-receptor histamine antagonists
Ganellin,Hosseini,Khalaf,Tertiuk,Arrang,Garbarg,Ligneau,Schwartz
, p. 3342 - 3350 (2007/10/02)
Starting from thioperamide, the first potent and selective H3-receptor histamine antagonist, analogues have been synthesized and tested in vitro on rat cerebral cortex to explore structure-activity relationships. The aim has been to design potent compounds which do not possess the thiourea group of thioperamide and which may have improved brain penetration. In a short series of open chain thiourea analogues, the optimum chain length for H3- antagonist potency was found to be (CH2)3. Compounds derived from histamine and possessing an aromatic nitrogen-containing heterocycle on the side chain amino group in place of thiourea show H3-antagonist activity. Furthermore, when the heterocycle is 2-pyridyl, electron-withdrawing substituents (e.g. NO2, CF3, CO2Me) in the pyridine 5-position increased potency. The synthesis of 4-[4(5)-imidazolyl]piperidine and its conversion into the (trifluoromethyl)pyridyl analogue 5b of thioperamide is described; however, 5b is not as potent as thioperamide. Replacing imidazole by pyridine or substituting imidazole on the remote N considerably reduced potency. Replacing the side-chain NH by S increased potency still further and the most potent compound is 2-{[2-[4(5)-imidazolyl]ethyl]thio}-5-nitropyridine (UCL 1199) which has K(i) = 4.8 nM.
